ESR1 and breast carcinoma: Considering different follow-up durations (Supplementary Table S5), the Sjögren cohort had a significantly higher risk of breast cancer due to estrogen receptor positivity, especially at shorter follow-up times (180 days and 1 year) (HR: 3.627 and 2.765, respectively).